BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25152340)

  • 1. Special considerations for children with hyperhidrosis.
    Bohaty BR; Hebert AA
    Dermatol Clin; 2014 Oct; 32(4):477-84. PubMed ID: 25152340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and treatment of primary focal hyperhidrosis in children and adolescents.
    Bellet JS
    Semin Cutan Med Surg; 2010 Jun; 29(2):121-6. PubMed ID: 20579601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary pediatric hyperhidrosis: a review of current treatment options.
    Gelbard CM; Epstein H; Hebert A
    Pediatr Dermatol; 2008; 25(6):591-8. PubMed ID: 19067862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on pediatric hyperhidrosis.
    Gordon JR; Hill SE
    Dermatol Ther; 2013; 26(6):452-61. PubMed ID: 24552408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sweat and tears: treating the patient with primary hyperhidrosis.
    Wheeler T
    Br J Nurs; 2012 Apr 12-25; 21(7):408, 410-2. PubMed ID: 22585018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hyperhidrosis on quality of life and its assessment.
    Hamm H
    Dermatol Clin; 2014 Oct; 32(4):467-76. PubMed ID: 25152339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Primary Focal Hyperhidrosis: An Algorithmic Approach.
    Liu V; Farshchian M; Potts GA
    J Drugs Dermatol; 2021 May; 20(5):523-528. PubMed ID: 33938689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and social isolation in Greek adolescents with primary focal hyperhidrosis treated with botulinum toxin type A: a case series.
    Kouris A; Armyra K; Stefanaki C; Christodoulou C; Karimali P; Kontochristopoulos G
    Pediatr Dermatol; 2015; 32(2):226-30. PubMed ID: 25557249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Type A botulinum toxin: a new methods in treating focal hyperhidrosis. A summary of various possibilities in hyperhidrosis therapy with special emphasis type A botulinum toxin injections].
    Kreyden OP; Böni R; Burg G
    Praxis (Bern 1994); 2000 May; 89(21):909-15. PubMed ID: 10859980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hyperhidrosis with botulinum toxin.
    Cohen JL; Solish N
    Facial Plast Surg Clin North Am; 2003 Nov; 11(4):493-502. PubMed ID: 15062254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhidrosis: review of recent advances and new therapeutic options for primary hyperhidrosis.
    Brown AL; Gordon J; Hill S
    Curr Opin Pediatr; 2014 Aug; 26(4):460-5. PubMed ID: 24905102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary focal hyperhidrosis: current treatment options and a step-by-step approach.
    Hoorens I; Ongenae K
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):1-8. PubMed ID: 21749468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary focal hyperhidrosis: scope of the problem.
    Glaser DA; Hebert AA; Pariser DM; Solish N
    Cutis; 2007 May; 79(5 Suppl):5-17. PubMed ID: 17596096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis, impact, and management of focal hyperhidrosis: treatment review including botulinum toxin therapy.
    Cohen JL; Cohen G; Solish N; Murray CA
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):17-30, v-vi. PubMed ID: 17317552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of the S1 guidelines on the definition and treatment of primary hyperhidrosis.
    Rzany B; Bechara FG; Feise K; Heckmann M; Rapprich S; Wörle B
    J Dtsch Dermatol Ges; 2018 Jul; 16(7):945-952. PubMed ID: 29989362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal hyperhidrosis: diagnosis and management.
    Haider A; Solish N
    CMAJ; 2005 Jan; 172(1):69-75. PubMed ID: 15632408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of hyperhidrosis].
    Maillard H; Lecouflet M
    Ann Dermatol Venereol; 2015 Apr; 142(4):252-61. PubMed ID: 25697587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palmar hyperhidrosis: long-term follow-up of nine children and adolescents treated with botulinum toxin type A.
    Coutinho dos Santos LH; Gomes AM; Giraldi S; Abagge KT; Marinoni LP
    Pediatr Dermatol; 2009; 26(4):439-44. PubMed ID: 19689521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between Dermatology Life Quality Index and Minor test and differences in their levels over time in patients with axillary hyperhidrosis treated with botulinum toxin type A.
    Skroza N; Bernardini N; La Torre G; La Viola G; Potenza C
    Acta Dermatovenerol Croat; 2011; 19(1):16-20. PubMed ID: 21489361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the patient presenting with hyperhidrosis.
    Solish N; Wang R; Murray CA
    Thorac Surg Clin; 2008 May; 18(2):133-140. PubMed ID: 18557587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.